Literature DB >> 12226030

The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis.

Lesley J Burgess1, Helmuth Reuter, Machteld E Carstens, J J Frans Taljaard, Anton F Doubell.   

Abstract

BACKGROUND: Traditional diagnostic tests for pericardial tuberculosis (TB) are insensitive and often require long culture periods, and this has led to more emphasis being placed on biochemical tests such as the pericardial adenosine deaminase (ADA) test. However, controversy exists as to its diagnostic utility. In addition, the use of interferon (IFN)-gamma, which is a reliable indicator of pleural and peritoneal TB, has not been explored in pericardial effusions. We investigated ADA and IFN-gamma levels in pericardial effusions of different etiologies. METHODS AND
RESULTS: A prospective study was carried out from February 1995 to February 1998 at Tygerberg Hospital (South Africa), with pericardial taps being performed under echocardiographic guidance. During this period, 110 consecutive patients presenting with large pericardial effusions were included in the study. Diagnoses were made according to predetermined criteria, and they included TB (n = 64), malignancy (n = 12), nontuberculous infections (n = 5), other effusions (n = 19), and effusions of uncertain origin (n = 10). The median ADA level in the tuberculous group was 71.7 U/L (range, 10.3 to 303.6 U/L), which was significantly higher than that in any other group (p < 0.05). With a cutoff level for ADA activity of 30 U/L, sensitivity was 94%, specificity was 68%, and positive predictive value was 80%. IFN-gamma levels were determined in 30 subjects. The median IFN-gamma concentration in the tuberculous group was > 1,000 pg/L, which was significantly higher than in any other diagnostic group (p < 0.0005). A cutoff value of 200 pg/L for IFN-gamma resulted in a sensitivity and specificity of 100% for the diagnosis of pericardial TB.
CONCLUSION: Pericardial fluid levels of ADA and IFN-gamma are useful in the diagnosis of tuberculous pericarditis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12226030     DOI: 10.1378/chest.122.3.900

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  25 in total

Review 1.  Diagnosis of tuberculous aetiology in pericardial effusions.

Authors:  G Cherian
Journal:  Postgrad Med J       Date:  2004-05       Impact factor: 2.401

Review 2.  Immortalization protocols used in cell culture models of human breast morphogenesis.

Authors:  T Gudjonsson; R Villadsen; L Rønnov-Jessen; O W Petersen
Journal:  Cell Mol Life Sci       Date:  2004-10       Impact factor: 9.261

3.  Comparative utility of cytokine levels and quantitative RD-1-specific T cell responses for rapid immunodiagnosis of tuberculous meningitis.

Authors:  Vinod B Patel; Ravesh Singh; Cathy Connolly; Victoria Kasprowicz; Thumbi Ndung'u; Keertan Dheda
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

4.  [Diagnostics and therapy of pericarditis and pericardial effusion].

Authors:  B Maisch; A D Ristić
Journal:  Herz       Date:  2014-11       Impact factor: 1.443

5.  [Differentiation of malignant from nonmalignant, inflammatory pericardial effusions with biomarkers].

Authors:  Konstantinos Karatolios; Peter Alter; Bernhard Maisch
Journal:  Herz       Date:  2009-12       Impact factor: 1.443

6.  Rational application of adenosine deaminase activity in cerebrospinal fluid for the diagnosis of tuberculous meningitis.

Authors:  Jorge Parra-Ruiz; V Ramos; C Dueñas; N M Coronado-Álvarez; R Cabo-Magadán; V Portillo-Tuñón; D Vinuesa; L Muñoz-Medina; J Hernández-Quero
Journal:  Infection       Date:  2015-04-14       Impact factor: 3.553

7.  Pleural fluid interferon-gamma and adenosine deaminase levels in tuberculosis pleural effusion: a cost-effectiveness analysis.

Authors:  S K Sharma; Amit Banga
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

Review 8.  Assessment by meta-analysis of interferon-gamma for the diagnosis of tuberculous peritonitis.

Authors:  Si-Biao Su; Shan-Yu Qin; Xiao-Yun Guo; Wei Luo; Hai-Xing Jiang
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

Review 9.  [New possibilities of diagnostics and therapy of pericarditis].

Authors:  B Maisch; K Karatolios
Journal:  Internist (Berl)       Date:  2008-01       Impact factor: 0.743

Review 10.  The common and distinct target genes of the p53 family transcription factors.

Authors:  K Harms; S Nozell; X Chen
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.